Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery.
about
Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapyPolypyrrole hollow microspheres as echogenic photothermal agent for ultrasound imaging guided tumor ablation.Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.High drug-loading nanomedicines: progress, current status, and prospects.Environment-dependent guest exchange in supramolecular hosts.Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.Linear-g-hyperbranched and cyclodextrin-based amphiphilic block copolymer as a multifunctional nanocarrier.Core-clickable PEG-branch-azide bivalent-bottle-brush polymers by ROMP: grafting-through and clicking-to.Drug-loaded, bivalent-bottle-brush polymers by graft-through ROMP.Simvastatin prodrug micelles target fracture and improve healing.Synthesis and Self-Assembly of a Mikto-Arm Star Dual Drug Amphiphile Containing both Paclitaxel and Camptothecin.Functional core/shell drug nanoparticles for highly effective synergistic cancer therapy.Synthesis, antitumor activity, and mechanism of action of 6-acrylic phenethyl ester-2-pyranone derivatives.Recent advances towards the fabrication and biomedical applications of responsive polymeric assemblies and nanoparticle hybrid superstructures.Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug releaseAmphiphilic Cyanine-Platinum Conjugates as Fluorescent Nanodrugs.Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release.Tunable self-assembly of Irinotecan-fatty acid prodrugs with increased cytotoxicity to cancer cells.pH-Responsive nanoparticles for drug delivery.Self-Assembly of Amphiphilic Drug-Dye Conjugates into Nanoparticles for Imaging and Chemotherapy.Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug releaseOptimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug.One-component nanomedicineEsterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.Building Nanostructures with Drugs.Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo.Core-shell nanocarriers with high paclitaxel loading for passive and active targeting.Cancer Theranostic Nanoparticles Self-Assembled from Amphiphilic Small Molecules with Equilibrium Shift-Induced Renal Clearance.A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery.A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic.Diverse Applications of Nanomedicine.Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide.Chimeric aptamers in cancer cell-targeted drug deliveryDevelopments in the use of nanocapsules in oncology.Supramolecular hydrogels: synthesis, properties and their biomedical applications.Stimuli-responsive polymersomes for cancer therapy.Programmed Nanococktail for Intracellular Cascade Reaction Regulating Self-Synergistic Tumor Targeting Therapy.Bioinspired Nano-Prodrug with Enhanced Tumor Targeting and Increased Therapeutic Efficiency.Peptide-drug conjugates as effective prodrug strategies for targeted delivery.
P2860
Q26858849-A293C7DD-67C0-44B2-9053-8D6B12EB8517Q30451264-30CE7A11-F9C0-4D30-89AD-FC6F3716D507Q30590874-CDE85975-8C84-4ED4-977C-2A0589164BD0Q33635355-7EF0D215-416A-4913-9962-A172E7508481Q33766568-D0542C9C-C838-4BF3-A388-665084763A3EQ34379933-8B994B0A-96CB-4BB4-B2EC-DA44C3DED3A2Q34532926-2228F3D0-DF40-4B9C-B790-EDABF552EFF2Q34751761-253C9667-C365-4604-BF60-7B59C58C08D0Q34798919-4E82D994-7210-44E3-84CE-BBD758A66744Q34868377-97B6D659-2687-44F6-AD51-37B2BC98B0D7Q35042849-D57C0FC5-648B-4208-9256-4C8EDB73BDDAQ35057136-A553A53C-CC0B-4791-BF74-326CA227E614Q35130422-0873A55C-D89C-49A4-A3DF-4FD6C1ADDE5EQ35329849-B639D331-CB3F-44E2-AD72-20A1DBE84BDEQ35541350-49EE0368-DCD4-4069-9841-8C6F78C0BC97Q35800930-69B1A925-9039-4C2B-8401-FC102966BD50Q35837874-B3B462A8-C8E9-43AA-B1B5-6D3AA8B48D46Q35921552-201658B8-C727-4906-8C60-495357812D2BQ36033702-026EC85F-67C1-4F22-B917-53CCB004B84DQ36047019-20B170E9-8F33-48C2-A394-B9A099817D7FQ36139312-B3635F97-F0CE-4D29-86C0-A6511730CB54Q36258999-E846FA4F-7902-471E-9B60-31EA69AA1BBFQ36268597-08ACCBE2-2033-4618-8E43-FF71F5ACCC8FQ36307689-EBE2E3DD-2CC2-4C52-BC7D-DDB8BC27D8ABQ36716649-1988EE81-D58C-49B1-9C3B-788F1ED6705DQ36766960-F83FDA45-AD0C-4A55-82CE-0CC1AA6230EBQ36944149-47B59B6A-349E-4733-8256-D263DC6FAEE1Q36986079-4B42BBFE-BE09-4485-BC17-1AFA9FE48999Q37112982-0AEAC316-0DF1-4F6B-9AE3-4AF6551B1DDFQ37222722-EA8605C3-CE1A-43FB-9F28-6ABA2E7FCC9AQ37393951-33ABDD36-8472-470E-A390-BD7FB21580DAQ37728142-9C0BF691-6A3C-4DD1-B797-71CE68185FE5Q37735009-487D5AF5-D936-4BCE-95BE-C82D4FA01FE7Q37939984-7573BC2E-94E1-4695-B381-3DDD60B2F97AQ38117157-07375B7E-F0EA-489E-A022-0F494F557FABQ38556753-B2BC8619-E5BA-4897-9B3D-61A065136761Q38604606-58BE6FF4-8043-4D4B-9298-F1E12FB97BADQ38808752-AF51D6F1-6441-462D-9516-7E9998396AB5Q38842836-A075F885-5CF8-43DF-A552-F59A141CED1AQ38883760-8C652EA3-A209-408F-A371-E922A63924B2
P2860
Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Prodrugs forming high drug loa ...... cellular cancer drug delivery.
@en
Prodrugs forming high drug loa ...... cellular cancer drug delivery.
@nl
type
label
Prodrugs forming high drug loa ...... cellular cancer drug delivery.
@en
Prodrugs forming high drug loa ...... cellular cancer drug delivery.
@nl
prefLabel
Prodrugs forming high drug loa ...... cellular cancer drug delivery.
@en
Prodrugs forming high drug loa ...... cellular cancer drug delivery.
@nl
P2093
P356
P1476
Prodrugs forming high drug loa ...... cellular cancer drug delivery.
@en
P2093
Caitlin J Murphy
Edward Van Kirk
Jianbin Tang
Jinqiang Wang
Maohong Fan
Meihua Sui
William J Murdoch
P304
P356
10.1021/JA909475M
P407
P577
2010-03-01T00:00:00Z